Abstract:In recent years, cancer therapy has envolved from traditional methods such as surgery, radiotherapy, chemotherapy, targeted therapies, including immuno-oncology (IO) This innovative approach uses the body the immune system’s role in fighting cancer cells has shown exceptional success. Biomarker testing, particularly PD-L1, is now mandatory before treatments such as pembrolizumab (Keytruda) for lung, stomach, head and neck cancer, and atezolizumab (Tecentriq) for cervical and endometrial cancer cancer but PD-L1… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.